Featured Content & Success Stories

At LSI 2021, Scott Huennekens, Chairman of the Board at Vida FLaSH Acquisitions sits down with Benjamin Glenn of A Matter of Innovation to discuss why this is the most exciting time in Medtech ever, what to do about those bumps in the road, the truth behind the magical journey of the unicorns and some advice on how to be a good leader, CEO or board member. This great discussion also covers the multi-tiered ecosystems that have emerged wherein apps, platforms, and data feed into a continuum of total care solutions, as well as the importance of bringing life-saving tech to the 7.5 billion people on the planet. AMOI Website

At LSI 2021, Adam Sachs, Co-Founder & CEO of Vicarious Surgical sits down with Benjamin Glenn of A Matter of Innovation to discuss his company's place at the forefront of minimally invasive robotic surgery, their recent SPAC merger, and how Vicarious plans to bring this groundbreaking technology to the world. AMOI Website

At LSI 2021, Lisa Carmel, VP of Strategy at Ximedica sits down with Benjamin Glenn of A Matter of Innovation to discuss how Ximedica works to guide and nurture new technologies emerging from both early-stage companies and larger strategics, (and everything in between). Lisa talks to Ben about the role of Ximedica within the larger ecosystem of Medtech. Highlights include mentions of Chris Velis's crystal ball predictions from LSI 2020. AMOI Website

At LSI 2021, Oliver Keown, MD, Director at Intuitive Ventures sits down with Benjamin Glenn of A Matter of Innovation to discuss his organization's mandate to invest globally, employing a widening aperture of investment outreach and bringing to bear the strength and experience of Intuitive's deep well upon an ever-expanding ecosystem of exciting new start-ups; casting a wide net across the spectrum of minimally invasive surgery, creating a continuum of end to end healthcare solutions and improving outcomes from diagnosis to recovery. AMOI Website

At LSI 2021, Bill Carpou, CEO of Octane OC sits down with Benjamin Glenn of A Matter of Innovation to have a conversation about Octane's recent realization as a content provider, balancing live events with virtual, expanding the reach of companies founded by women and people of color within the industry, as well as the opportunity for a united Southern California to reach full potential with a unified AI strategy and to have a fully realized collective impact on the future of healthcare. Ben and Bill also discuss the four pillars of Octane's mission to build successful companies through content, community, capital & consultation in both Tech and Medtech. AMOI Website

At LSI 2021, Kwame Ulmer, Venture Partner at Wavemaker Three-Sixty Health sits down with Benjamin Glenn of A Matter of Innovation to discuss "belief capital", educating early-stage entrepreneurs on what investors are looking for, when to talk to the FDA, and the importance of knowing what you don't know. AMOI Website

At LSI 2021, Jennifer McCaney PhD (Co-Executive Director UCLA Biodesign) & Kwame Ulmer (Venture Partner at Wavemaker Three-Sixty Health) sit down with Benjamin Glenn of A Matter of Innovation to discuss the new UCLA Biodesign curriculum and their landmark study which asks the question:

"What does it take to bring a novel medical technology to market in the year 2021?"

A variety of interesting healthcare topics are also explored in this in-depth interview. AMOI Website

At LSI 2021, Cristian Atria, Founder & CEO of nView Medical sits down with Benjamin Glenn of A Matter of Innovation to discuss his company's exciting new real-time 3-D imaging for surgeons, creating better outcomes for children's surgeries, new ways of looking at start-ups and how they fashion themselves to better suit a potential future acquisition partner, and the similarities between the arc of surgical innovations and those in the field of professional racing. AMOI Website

At LSI 2021, Philip D. Rackliffe, CEO of Centerline Biomedical sits down with Benjamin Glenn of A Matter of Innovation to discuss Centerline Biomedical's new Endovascular Navigation Technology, the powerful story behind the technology's origins, huge advances in the mitigation of radiation exposure during OR time, inspiring tales of surgical successes and the great benefits of developing innovation in the Heartland. AMOI Website

At LSI 2021, Tiffany Wilson, CEO of University Science Center sits down with Benjamin Glenn of A Matter of Innovation to talk about taking on a new role in a new city during COVID, the next chapter in the Science Center's life as a collaborative partner and its role in cultivating 21st century talent, business and civic engagement in their region, her time in the Obama Administration's Startup America program, the importance of educating an army of the STEM and digitally literate and the idea that successful bio tech companies are not built purely on science. AMOI Website

At LSI 2021, Chris Velis, Founder & Executive Chairman of Miraki Innovation sits down with Benjamin Glenn of A Matter of Innovation to discuss the exponential increase in convergence of industries within healthcare, predictions for the future of patient care and early intervention, Miraki's unique approach to building companies, (beginning with the problem and wrapping an entire community around that problem), BOA Biomedical's rapid pathogen identification and their filter to remove toxins, the importance to entrepreneurs of seeing their technology not as their entire company, but as the vision of where they are to go, and the possibility of adding a fourth day to the LSI conference. AMOI Website 

At LSI 2021, Terri Burke, Venture Partner at Epidarex Capital sits down with Benjamin Glenn of A Matter of Innovation to discuss what the data says about shifting trends in medtech investment, getting to know your potential investors before the pitch, changes brought on by the pandemic, (some of which might be for the good), her organization's partnership with Sante and others to serve patients suffering from ischemic stroke, how lessons learned in other areas of life can be harvested to bring resilience and agility to the approach you take to your business, and "beginning with the end in mind". AMOI Website

At LSI 2021, Dennis McWilliams, Partner at Santé sits down with Benjamin Glenn of A Matter of Innovation to discuss his move from serial entrepreneurship (Apollo Endosurgery, Chrysalis BioTechnology) to the investment side of the industry, adventures in early-stage investment, Santé's venture fellowship program, their partnership with Intuitive Surgical, the critical mass of investment in the life sciences within the Texas ecosystem, the convergence of medtech, bio-tech, and health-tech, his teaching and lectures on entrepreneurship and innovation for the B.E.S.T. Innovations Courses (taught at the prestigious IHU Institut de Chirurgie Guidée Par L'lmagein Strasbourg, France) -a partnership with Epidarex and others to better serve patients suffering from ischemic stroke, and the value of personal health rejuvenation time, hiking, beards and card tricks. AMOI Website

Scott Pantel, Founder & CEO of LSI & Emerging Medtech Summit, sits down with Benjamin Glenn of A Matter of Innovation at #LSI2021 Life Science Intelligence to discuss his market intelligence company’s data driven commitment to curating the perfect mix of innovators, investors and strategics that are the future of healthcare, the practical process that leads to so many successful investments, keeping a finger on the pulse of industry trends, the current emphasis on digital surgery, back-to-back panels bringing together 170 innovators with a total of 400 exits (worth billions) with sincere, active investors; dispelling the myths about SPACs, powerful and insightful keynotes, beautiful dinners by the Pacific Ocean, prescient predictions, meeting the challenge of hosting a safe in-person event, and a big thank you to friends and supporters whose commitment to the industry continues to bring life saving technologies to the patients who need them. AMOI Website

David Uffer, Partner at Alira Health, sits down with Benjamin Glenn of A Matter of Innovation at #LSI2021 Life Science Intelligence to discuss what the data says about COVID - era investments, Alira’s presence in the UK, Milan & Asia PAC, the importance of maintaining involvement in your local ecosystem, how simply having an amazing technology does not build a successful Medtech company, Alira’s partnership with Ximedica, how a CEO must be a Jack of all Trades while also knowing when to pick an expert and leave it to them,  Alira’s partnership with University City Science Center in Philly, the mission of the Science Center and Tiffany Wilson’s work within that extremely ripe ecosystem, the importance of giving back & helping early stage companies find guidance and funding,  avoiding value dilution and other errors through guidance and advice, building value dossiers, taking strategy from design at the beginning, and sleepless nights for the cause.

Dr. Sean J. Cheng, Partner at Philips Ventures sits down with Benjamin Glenn of A Matter of Innovation at #LSI2021 Life Science Intelligence to discuss what he calls a seminal moment for the industry, the surprise record investment period during Covid, the best ways for entrepreneurs to approach Philips  Ventures with new technologies, their new footprint in the Cambridge Commons, what makes Boston the hot place to be for Medtech for the next 10 years, mentoring the next generation of inventor-founders, Philips’ “Quadruple Aim” - a 4-pronged approach to innovation that centers on the patient experience, the physician & clinician’s experience, better outcomes, and lowering the cost of life saving technologies. 

Stephen Ralph, Global Executive, Commercial Leader & Marketing Strategist for Gore, sits down with Benjamin Glenn of A Matter of Innovation at #LSI2021 Life Science Intelligence to dive deep on Gore’s vertical strategy, how a material science company enables medical and industrial technologies that improve experience for the four “P”s: patients, physicians, payers, and providers, Gore’s vigorous phase-gate process for choosing which technologies in which to invest resources, encouraging entrepreneurs to think holistically-with market fit in mind, (how most projects fail because they miss this point), Gore’s rapid interview process for patient discovery-100 interviews conducted by an engineer, a marketing rep and a clinical expert (all part of the project team), and the unprecedented present era for medtech with advances in personalized medicine, remote patient monitoring and guided therapies.

Nick Pachuda, Senior Vice President, Portfolio & Development with Peptilogics, sits down with Benjamin Glenn of A Matter of Innovation at #LSI2021 Life Science Intelligence to discuss his  company’s work to revolutionize the way the world sees peptides with computational drug design and purpose-built synthetic peptides, the benefits to investors at all levels to partnering early, the advantages of building ecosystem in the middle of the country, the great work happening at Mountain State Capital, how “deals get done because two people agree on a need and a solution”, the valuable, actionable insights and the “truly compelling start-ups” to be found at LSI.

Lloyd Diamond, CEO at Pixium Vision, sits down with Benjamin Glenn of A Matter of Innovation at #LSI2021 Life Science Intelligence to discuss his company Pixium Vision’s amazing new retinal implant, developed in conjunction with Stanford- giving patients who are legally blind the gift of sight, (the technology offers those suffering from the dry form of age related macular degeneration the ability to regain their detailed central vision), allowing them to once again cook, take the right medications at the right time, pass vision tests they had failed in the past, and to see their grandchildren’s faces again; the value of offering this technology to elderly patients, how age is a mental state, not a number; the supportive ecosystem of the Passage de L’Innovation in Paris, and how Medtech investments function in France.

Daniel Hawkins , CEO at Avail Medsystems, sits down with Benjamin Glenn of A Matter of Innovation at #LSI2021 Life Science Intelligence to discuss his company’s telepresence and growing network of practitioners, experts, tech advisors and proctors; eliminating  physical barriers and  inefficiencies to create more freedom for the clinician’s hands to reach more patients faster; his technology’s ability to bring vital staff into the operating room from a remote location, provide device support, surgical expertise and a network of experts to choose from; traveling 1/4 of a million miles for a single company in one year, meeting his own clinical need in order to inform the design of an innovative technology, raising 150 million in an accelerated demand for Avail’s remote telemedical services, helping to set right the unfortunate data that shows 50-60 percent of a practitioner’s time is spent on logistics,  and how the word "avail" is perfect for his company- employing both meanings of the word.

John White, Principal & Investor at KCK Medtech sits down with Benjamin Glenn of A Matter of Innovation at #LSI2021 Life Science Intelligence to discuss his best advice on when to approach KCK, how to evaluate and help grow sustainable medical device companies, digital health before it was called “digital health”, drawing on experience from Stanford Biodesign, Boston Scientific, Gore’s Innovator Workbench, putting together a set of tools that bring experience to bear, playing off the happy accident as if were on purpose, how the public’s awareness has grown through Covid, (for example: people now know and perhaps care more about how vaccines are made and regulated), how the industry and the Emerging Medtech summit are both all about  the relationships you make along the way, watching those relationships come full circle, and meeting the challenges of the complexities inherent to delivering life saving technologies to the people who need them.